CEL-SCI CORP Files 8-K: Material Definitive Agreement

TL;DR

CELC just signed a big deal, filing an 8-K. Could be huge.

AI Summary

On August 27, 2025, CEL-SCI CORPORATION (CELC) entered into a material definitive agreement. The company, incorporated in Colorado with its principal executive offices in Vienna, VA, filed an 8-K report detailing this event. The filing also includes other events and financial statements and exhibits.

Why It Matters

This 8-K filing indicates a significant new agreement for CEL-SCI CORPORATION, which could impact its business operations and future financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, requiring further analysis to determine the overall impact.

Key Players & Entities

• CEL SCI CORP (company) — Registrant
• August 27, 2025 (date) — Date of earliest event reported
• 8229 Boone Blvd. #802 Vienna, VA 22182 (address) — Principal executive offices
• 703-506-9460 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.01 — ch Registered Common Stock, par value $0.01 per share CVM NYSE American Indica
• $9.00 — s common stock, at an offering price of $9.00 per share (the "Shares"). The Offering
• $10,000,800 b — ds from the Offering were approximately $10,000,800 before deducting Placement Agent fees and
• $185,000 — l counsel) in an aggregate amount up to $185,000. The Company further agreed not to issu

Filing Documents

• cvm_8k.htm (8-K) — 32KB
• cvm_ex11.htm (EX-1.1) — 268KB
• cvm_ex51.htm (EX-5.1) — 6KB
• cvm_ex991.htm (EX-99.1) — 11KB
• cvm_ex992.htm (EX-99.2) — 11KB
• cvm_ex992img2.jpg (GRAPHIC) — 5KB
• cvm_ex991img3.jpg (GRAPHIC) — 5KB
• 0001654954-25-010184.txt ( ) — 528KB
• cvm-20250827.xsd (EX-101.SCH) — 5KB
• cvm-20250827_lab.xml (EX-101.LAB) — 14KB
• cvm-20250827_cal.xml (EX-101.CAL) — 1KB
• cvm-20250827_pre.xml (EX-101.PRE) — 9KB
• cvm-20250827_def.xml (EX-101.DEF) — 2KB
• cvm_8k_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On August 27, 2025, CEL-SCI Corporation, a Colorado corporation (the "Company"), entered into a Placement Agency Agreement with ThinkEquity LLC (the "Placement Agent") relating to the sale and issuance of 1,111,200 shares of the Company's common stock, at an offering price of $9.00 per share (the "Shares"). The Offering closed on August 29, 2025. The gross proceeds from the Offering were approximately $10,000,800 before deducting Placement Agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering to fund the continued development of Multikine, for general corporate purposes, and working capital. The securities were offered and sold by the Company pursuant to the Company's effective registration statement on Form S-3 (Registration No. 333-288515) which was declared effective by the Securities Exchange and Commission (the "SEC") on August 12, 2025, the base prospectus included therein, as amended and supplemented by the prospectus supplement dated August 27, 2025. Pursuant to the terms of the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds of the Offering and to reimburse the Placement Agent for certain of its expenses (including fees and expenses of its legal counsel) in an aggregate amount up to $185,000. The Company further agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock or file any registration statement or prospectus, or any amendment or supplement thereto for a period of 30 days from the closing of this offering, subject to certain exceptions. Additionally, each of the directors and officers of the Company, pursuant to lock-up agreements, agreed not to sell or transfer any of the Company secur

01 Other Events

Item 8.01 Other Events. On August 27, 2025, the Company issued a press release announcing the pricing of the Offering, which press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. On August 29, 2025, the Company issued a press release announcing the closing of the Offering. A copy of this press release is attached as Exhibit 99.2. The information in this Item 8.01, including Exhibit 99.1 and 99.2 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Forward-Looking Statements Certain of the statements made in this Current Report on Form 8-K are forward looking. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. More information about the risks and uncertainties faced by the Company is contained under the caption "Risk Factors" in the Company's prospectus supplement filed with the SEC on August 27, 2025 pursuant to Rule 424(b)(5) promulgated under the Securities Act, the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024 filed with the SEC on January 13, 2025, and other filings made by the Company with the SEC, all of which can be obtained on the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. The Company expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 1.1 Placement Agency Agreement dated August 27, 2025, by and between CEL-SCI Corporation and ThinkEquity, LLC 5.1 Opinion of Hart & Hart, LLC 23.1 Consent of Hart & Hart, LLC (included in Exhibit 5.1) 99.1 Press Release dated August 27, 2025 99.2 Press Release dated August 29, 2025 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 29, 2025 CEL-SCI CORPORATION By: /s/ Geert Kersten Geert Kersten Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR